49. Systemic lupus erythematosus Clinical trials / Disease details
Clinical trials : 946 / Drugs : 722 - (DrugBank : 186) / Drug target genes : 117 - Drug target pathways : 199
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01359826 (ClinicalTrials.gov) | October 2011 | 19/4/2011 | The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients | The Effect of Milnacipran on Fatigue and Quality of Life in a Lupus Cohort | Systemic Lupus Erythematosus;Widespread Pain;Fibromyalgia | Drug: Milnacipran | Loma Linda University | Forest Laboratories | Withdrawn | 18 Years | N/A | Both | 0 | Phase 4 | United States |